Introduction

Animals and treatment
Oral contraceptives are widely used; therefore, their effect on
The rats used in the present study were treated and handled according to the risk of breast cancer is important. Most epidemiological the Recommendations for Handling of Laboratory Animals for Biomedical studies suggest that there is no association between the use of Research compiled by the Committee for the Safety and Handling Regulations for Laboratory Animal Experiments in our institute. Wistar-MS rats were kept oral contraceptives and the risk of breast cancer (1) (2) (3) (4) , but at 23 Ϯ 1°C in a controlled environment (14 h light-10 h dark) and received some suggest that the risk of breast cancer increases with the water and food ad libitum. For the first experiment, 24 virgin female rats, duration of use before the first full-term pregnancy (5, 6) , and 2.5 months of age, were implanted subcutaneously with the high-dose pellets commencement of use at a young age (7, 8) . Oral contraceptives for 1 month, and then were irradiated with 2.6 Gy γ-rays (0.15 Gy/min) from a 60 Co source. Cholesterol pellets were implanted in 23 virgin rats as the control. The pellets implanted were removed from the rats 1 month after Abbreviations: AC, adenocarcinoma; EE 2 , 17α-ethinylestradiol or (17α)-19-norpregn-1,3,5(10)-trien-20-yne-3,17-diol; ER, estrogen receptor; FA, fibroirradiation. The irradiated rats were observed for 1 year for the development of palpable mammary tumors ( Figure 2 ). adenoma; FSH, follicle-stimulating hormone; LH, luteinizing hormone; MBS, maximum binding sites; NET, 19-norethisterone or (17α)-17-hydroxy-19-For the treated group in the second experiment, 18 virgin female rats (2.5 months old) were implanted subcutaneously with the low-dose pellet of EE 2 -norpregn-4-en-20-yn-3-one; PgR, progesterone receptor; R5020, 17α-methyl-17-propionylestra-4,9-dien-3-one.
NET in the interscapular area. The hormone-treated rats were then irradiated analysis of steroid receptors. Tumor incidence was calculated from the number of rats with mammary tumors within 1 year. Iball's index of mammary tumors was calculated as follows: the ratio of incidence (%) to the average latency period in daysϫ100 (17) . For the determination of biological effects and morphological change by pre-treatment with the hormone pellets before irradiation, five virgin rats per group, 2.5 months of age, were implanted with the cholesterol pellets or the low-or high-dose pellets of EE 2 -NET. One month later, corresponding to the time of irradiation, all rats were killed for examination. Fig. 1 . Chemical structures of EE 2 and NET.
Histological examination At the time of irradiation and at the end of the experiments in virgin rats treated with high-or low-dose pellets, and in parous rats, whole mounts of mammary glands were prepared for evaluation of development according to the methods of Rothschild et al. (18) with modification (14) . Briefly, the entire inguinal mammary glands were dissected and spread on filter paper. The specimens were fixed for 1 day in 10% formalin buffered with 0.1 M phosphate buffer pH 7.2, stained with alum carmine for 3 h, destained in ethanol and stored in cedar oil. The mammary tumors removed were fixed immediately in 10% neutral buffered formalin and embedded in paraffin. Paraffin sections (4 µm thick) were prepared and stained with hematoxylin and eosin. The tumors were classified as fibroadenoma (FA) or adenocarcinoma (AC) according to the criteria for the classification of rat mammary tumors (19).
Assays of hormones
At the time of irradiation and at the end of the experiments, blood samples collected from five rats of each group by cardiocentesis under Nembutal anesthesia were allowed to clot and then centrifuged to obtain sera. Concentrations of prolactin, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in each serum sample were determined with NIDDK radioimmunoassay kits (National Hormone and Pituitary Program). Sensitivities were 0.2 ng/ml serum for LH, FSH and prolactin.
Assay of steroid receptor in mammary tumors
Each tumor tissue (1 g) dissected was homogenized in ice-cold 10 mM TrisHCl buffer pH 7.4 containing 1.5 mM EDTA-Na 2 and 1 mM dithiothreitol.
Homogenates were centrifuged at 105 000 g for 1 h at 4°C, and the cytosol fraction was used for assay of the receptors. Both estrogen receptor (ER) and progesterone receptor (PgR) in the cytosol fraction were analyzed by a dextran-coated charcoal method using [2, 4, 6, H]estradiol-17β and [17α-methyl-3 H]R5020, respectively, as radioligands (20, 21) . Dissociation constant (K d ) values and maximum binding sites (MBS) for the receptors were determined by a Scatchard plot analysis (22) .
Statistical analysis
All statistical analyses were performed using StatView-4.5J (Abacus Concepts, Berkeley, CA). Statistical analyses were conducted by χ 2 test for tumor incidence and for the proportion of AC and FA, and by Student's t-test for body and organ weight, latency period and hormone concentrations. The cumulative proportions of rats with tumors (incidence curves) were calculated by the product-limit method where rats that died or were killed without mammary tumors were included, and the difference between groups was tested for statistical significance by the Mantel-Cox test. Probability values Fig. 2 . Experimental protocol used in this study. Open and shaded Ͻ5% were considered significant. arrowheads pointing up, implantations of the pellets of cholesterol and EE 2 -NET, respectively; open and shaded arrowheads pointing down, withdrawal of the cholesterol pellets and the high-dose pellets of EE 2 -NET,
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respectively; closed arrow, whole-body irradiation with 2.6 Gy γ-rays; open bar, period of cholesterol treatment; shaded bar, period of treatment with
Modification of radiation-induced mammary tumors in virgin
EE 2 -NET; number, months of age; Preg., pregnancy; Lact., lactation.
rats by administration of the high-dose pellets
In the control experiments, 23 virgin rats were implanted with with 2.6 Gy γ-rays 1 month after implantation. The estrous cyclicity of the rats in this group was monitored by examination of vaginal smears prepared the cholesterol pellets at the age of 2.5 months and irradiated between 09:30 and 10:30 h daily from the beginning of implantation of the with 2.6 Gy at 3.5 months. The pellets were removed 1 month low-dose pellets until irradiation. A plastic tube containing 0.9% saline was after the irradiation. Five rats (21.7%) developed mammary inserted a few millimeters into the vagina. The saline was flushed gently into tumors over the 1 year period (Table I ). The implantation of the vagina, collected and placed onto a slide glass. Cornified cells, epithelial cells and leukocytes were stained with Giemsa's solution, and identified the high-dose pellets of EE 2 -NET instead of the cholesterol through a light microscope. Twenty-seven age-matched control rats received pellets in 24 virgin rats significantly increased the incidence cholesterol pellets of equivalent weight.
(58.3%) of mammary tumors (P Ͻ 0.01). The cumulative Fifty-two parous rats were used in the third experiment. They were divided incidence curve of mammary tumors in the irradiated virgin into two groups 1 month after irradiation with 2.6 Gy γ-rays at weaning. The rats implanted with the high-dose pellets increased significantly low-dose pellets were implanted in 20 rats for the experimental group. For the control group, 32 rats were implanted subcutaneously with the cholesterol (P Ͻ 0.05) within the 1 year period compared with the control pellets. In the second and third experiments, the hormone and cholesterol group ( Figure 3a) . No significant differences in the proportion pellets were replaced every 2 months until the end of the experiments. The of ACs and FAs (P ϭ 0.315), in the number of tumors per rats were observed for 1 year for palpable mammary tumors. When palpable tumor-bearing rat (P ϭ 0.446) or in latency periods (P ϭ tumors reached Ͼ2 cm in diameter, the rats bearing them were killed by CO 2 asphyxiation and the tumors were removed for histological examination and 0.205) were observed between the cholesterol-treated group and the high-dose hormone pellet-treated group (Table I) .
Modification of radiation-induced mammary tumors in parous
Iball's index for the development of mammary tumors in the rats by administration of the low-dose pellets irradiated rats implanted with the high-dose pellets was 2.4-Of the 32 rats administered whole-body irradiation with 2.6 fold that in the rats treated with the cholesterol pellets.
Gy γ-rays during lactation and then treated with the cholesterol Modification of radiation-induced mammary tumors in virgin pellets, 10 (31.3%) developed mammary tumors during the rats by administration of the low-dose pellets experimental period (Table II) . The administration of the lowIn the control experiments, 27 virgin rats were implanted with dose pellets in 20 experimental rats 1 month after the irradiation the cholesterol pellets from the age of 2.5 to 16.5 months and significantly increased the incidence (90.0%) of total mammary administered whole-body irradiation with 2.6 Gy at the age of tumors (P Ͻ 0.0001). The cumulative incidence curve of 3.5 months, 1 month after the first implantation. Nine rats mammary tumors in the irradiated parous rats implanted with (33.3%) developed mammary tumors during the experimental the low-dose pellets increased significantly (P Ͻ 0.0001) periods (Table I ). The implantation of the low-dose pellets in within the 1 year period compared with the control ( Figure  18 experimental rats did not change the incidence (33.3%) of 3c). ACs did not develop in the rats irradiated while lactating the mammary tumors induced by radiation. No significant and then implanted with the cholesterol pellets. However, on difference (P ϭ 0.910) in the cumulative incidence curves treatment with the low-dose pellets, ACs developed in 27 was observed between the control rats and the rats treated (57.5%) of 47 tumors examined. Also, there were significant with the low-dose pellets (Figure 3b) . No AC developed in differences between the two groups in the proportion of ACs the virgin rats administered the low-dose pellets before and and FAs (P Ͻ 0.0001), and in the numbers of mammary tumors after irradiation (Table I) . No significant difference in the per tumor-bearing rat (P Ͻ 0.05). However, no significant proportion of ACs and FAs (P ϭ 0.142), in the numbers of difference in latency periods until the appearance of the first tumors per tumor-bearing rat (P ϭ 0.752) or in latency periods tumor (P ϭ 0.189) was observed between the two groups. By (P ϭ 0.278) was observed between the control and the administration of the low-dose pellets in the irradiated parous hormone-treated groups in the virgin rats. Iball's index for rats, Iball's index was enhanced 3-fold in comparison with the overall development of mammary tumors in the hormonetreated rats was almost the same as that in the control group.
that of the cholesterol-treated rats. weight (P Ͻ 0.05) compared with the control were observed 
Concentrations of pituitary hormones in serum at the end of
The concentrations of pituitary hormones were assayed using a Significant difference from the control group treated with cholesterol, serum collected 2 months after the last implantation of
pellets. The serum prolactin concentration in the virgin rats treated with the low-dose pellets was 6.3 times (P Ͻ 0.01) that in the control rats (Table IV) . No change in the concentraBiological effect and hormonal change at the time of irradiation tion of LH and FSH was observed in the virgin rats treated Virgin rats implanted with the low-dose pellets showed a long term with the low-dose pellets. In the rats irradiated with persistent estrous, indicated by vaginal smear. The body weight γ-rays during lactation and then implanted with the lowwas significantly decreased (P Ͻ 0.01) in virgin rats by dose pellet, the prolactin concentration was increased 9.5-fold treatment with the low-and high-dose pellets (Table III) .
(P Ͻ 0.01) compared with the cholesterol-implanted rats, but Administration of the low-dose pellets induced atrophy of the the concentrations of LH and FSH were comparable to the ovaries with multiple small cysts and atrophy of the liver, and control value. When the virgin rats were administered the hypertrophy of the uterus with the presence of a substantial high-dose pellets from 2.5 to 4.5 months of age and irradiated amount of intraluminal fluid. No change in the weight of at age 3.5 months, no significant difference in the serum pituitary glands and prolactin concentration was observed in concentration of pituitary hormones was observed at the end the virgin rats on short-term administration of the low-dose of the experiments. pellets. However, the serum prolactin concentration in the virgin rats treated with the high-dose pellets for 1 month was Whole mounts of mammary glands at the time of irradiation 3-fold (P Ͻ 0.01) that in the control rats, in spite of no change and at the end of the experiments in the weight of pituitary glands.
Whole mounts of the mammary glands were prepared from Biological effect at the end of the experiments female rats at the age corresponding to the time of irradiation. Mammary glands in the virgin rats treated with the low-or The body weight was significantly decreased (P Ͻ 0.01) in high-dose pellets for 1 month were observed to have wellvirgin rats by long-term treatment with the low-dose developed lobulo-alveoli with expanded lactiferous ducts in pellets (Table IV) in spite of a similar calorie intake the glands more than those in the rats implanted with the (63.6 Ϯ 1.1 kcal/rat/day) to the control group (64.5 Ϯ cholesterol pellets (Figure 4a-c) . At weaning, alveolar lumina 1.3 kcal/rat/day). The rats implanted with the low-dose in the mammary glands were extensively dilated and milk hormone pellets in both virgin and parous groups had filled. No adipose cells were visible (Figure 4d ). enlarged pituitary glands, which presented macroscopically At the end of the experiments, mammary glands were friable hemorrhagic tumors. On administration of the lowslightly developed in the virgin rats implanted with the highdose pellets to the virgin rats, atrophy of the ovaries in dose pellets during the initiation with γ-rays ( Figure 5a and comparison with the control (P Ͻ 0.05) occurred, and a b), and proliferated in the virgin rats implanted continuously tendency to hypertrophy was observed in the liver (P ϭ with the low-dose pellets for 1 year (Figure 5c and d) . No 0.183) and uterus (P ϭ 0.199). Also, a significant reduction of body weight (P Ͻ 0.01) and an increase of pituitary significant difference in the development of mammary glands Each value represents the mean Ϯ SE obtained from five rats. a Significant difference from the control treated with cholesterol, P Ͻ 0.01. b Significant difference from the control treated with cholesterol, P Ͻ 0.05. was observed between the irradiated parous rats implanted ER ϩ PgR ϩ and five ER -PgR -tumors were detected. The with the cholesterol pellets and those implanted with the lowtumors of ER ϩ PgR ϩ type and ER -PgR -type disappeared on dose pellets (Figure 5e and f) . administration of the low-dose pellets to the irradiated virgin rats, and all tumors tested were ER ϩ PgR -. Conversely, tumors Steroid hormone receptors in mammary tumors that developed in the rats irradiated during lactation and then In the virgin rats implanted with the high-dose pellets for 2 treated with the cholesterol pellets were ER positive, and no months at 2.5 months of age and irradiated at age 3.5 months, ER -PgR -tumor was detected. Many (64%) of the mammary two ER ϩ PgR ϩ , three ER ϩ PgR -and nine ER -PgR -tumors tumors obtained from the rats irradiated during lactation and developed within 1 year (Table V) . In the virgin rats implanted with the cholesterol pellets and irradiated with γ-rays, two then treated with the low-dose pellets were ER ϩ PgR -and only (MPA), as a contraceptive (27) or an effective agent for breast pills in that they contain a low dose (Ͻ0.05 mg/pill) of EE 2 combined with varying doses of the progestins, such as NET, levonorgestrel or desogestrel (29) . Dilatation of acini and ducts two tumors (7.1%) were ER -PgR -. acetate/kg/day) in sexually mature female rhesus monkeys the rats irradiated during lactation were reduced by long-term over a 10 year period (30) . However, the long-term administraadministration of the low-dose pellet, but not significantly tion of an oral contraceptive mixed with EE 2 -3-methylether (P ϭ 0.086 for ER and P ϭ 0.378 for PgR, respectively). FAs and WY-4355 induced a high incidence of malignant mammary that developed in the irradiated virgin rats treated with the tumors in female beagle dogs (31,32). The present study indicates that long-term treatment with the low-dose pellets cholesterol or hormone pellets for 1 year were PgR negative. did not modify the risk of mammary tumors initiated with by treatment with the high-dose pellet of EE 2 -NET before radiation in virgin rats (incidence 33.3% in control versus irradiation also have a tendency to develop into FAs in the 33.3% by EE 2 -NET); however, it significantly increased the presence of physiological hormones secreted from the ovaries, risk in parous rats irradiated during lactation (incidence 31.3% because of elimination of the pellet used as initiation modifier in control versus 90.0% by EE 2 -NET, P Ͻ 0.0001). At the time after irradiation. From those results, it is suggested that the of irradiation, the mammary glands were weakly developed by primordial cells or stem cells in the lactating mammary glands the pre-treatment with the low-dose hormone pellets in virgin differ in their disposition to radiation from those in the glands rats, and were markedly differentiated during the lactation of developed with EE 2 -NET. parous rats. The extent to which mammary tumorigenesis is Regarding the association between EE 2 and radiation, initiated by radiation is dependent on the developmental stage Holtzman et al. (9) reported that the final incidence of of the mammary glands at the time of irradiation (15, 16) . The mammary AC was no different between rats treated with EE 2 more advanced the stage, the higher the rate of mammary and X-rays versus rats treated with EE 2 alone. On the other tumorigenesis. Also, irradiation of virgin rats implanted with hand, regarding the association between oral contraceptives the high-dose pellets resulted in a significantly higher incidence and chemical carcinogens, Welsch and Meites (33) have (58.3%, P Ͻ 0.01) of tumors than that (21.7%) of rats reported that Enovid (98.5% norethynodrel and 1.5% EE 2 -3-implanted with the cholesterol pellets. These findings suggest methylether) significantly inhibited the development of 7,12-that the risk for radiation-induced mammary tumorigenesis dimethylbenz[a]anthracene-induced mammary tumors, but depends on the dose of estrogen and progestin in the pellet, enhanced the growth of those mammary tumor cells already whether it is implanted before or after irradiation, and also on present. Using normal, non-malignant atypical and malignant the developmental stage of mammary glands at irradiation.
human mammary epithelial cells, it was found that the oral No AC developed in the parous rats irradiated during contraceptive mixed with EE 2 -3-methylether and NET prolactation and implanted with cholesterol pellets as the control.
moted the growth of previously transformed cells, rather than However, in those implanted with the low-dose pellet instead the transforming event by carcinogen initiation (34) . Also, of the cholesterol pellet, the proportion of ACs increased Baggs et al. (35) reported that EE 2 -NET did not increase the significantly to 57.5% of the total tumors. On the other hand, risk of developing vaginal tumors in female rat offspring the proportion of ACs in the total tumors in the null-parous treated in utero with DES. irradiated rats decreased from 23.1% for the cholesterol pellet
In conclusion, the current investigation demonstrates that as the control to 0% for the low-dose pellet of EE 2 -NET, and long-term administration of the low-dose pellets of EE 2 -NET from 28.6% in the control to 11.8% for the high-dose pellet.
increases the risk of developing mammary tumors in parous In the initiation phase with the radiation, the primordial cells rats irradiated at weaning, but not in rats irradiated while or stem cells in the mammary glands that develop during virgins. The risk of radiation-induced mammary tumorigenesis pregnancy and following lactation have a tendency to become increased in virgin rats previously administered the high-dose ACs in the presence of the low-dose pellet of EE 2 -NET as a pellets of EE 2 -NET. tumor promoter. However, primordial cells or stem cells in the glands developed by treatment with the low-dose pellet ofalso by a grant from the Special Program for Bioregulation of the National 18. Rothschild,T.C., Boylan,E.S., Calhoon,R.E. 
